Evaluation of twenty-one human adenovirus types and one infectivity-enhanced adenovirus for the treatment of malignant melanoma

Journal of Investigative Dermatology

Volumn 128, Issue 4, 2008, Pages 988-998

  Hoffmann, Dennis ^a   Bayer, Wibke ^a   Heim, Albert ^b   Potthoff, Anja ^c   Nettelbeck, Dirk M ^d,e   Wildner, Oliver ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c ST JOSEF HOSPITAL   (Germany)

^d UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^e UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; DACARBAZINE; MEMBRANE GLYCOPROTEIN F; MEMBRANE GLYCOPROTEIN H; MEMBRANE PROTEIN; ONCOLYTIC ADENOVIRUS; UNCLASSIFIED DRUG;

ADENOVIRUS; ADENOVIRUS 35; ADENOVIRUS 5; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; MEASLES VIRUS; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; ONCOLYTIC VIROTHERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; XENOGRAFT;

EID: 40649109345     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5701131     Document Type: Article

References (86)

1. A. Ahmed D. Jevremovic K. Suzuki T. Kottke J. Thompson S. Emery Intratumoral expression of a fusogenic membrane glycoprotein enhances the efficacy of replicating adenovirus therapy Gene Ther 10 2003 1663 1671
2. R. Alemany C. Balague D.T. Curiel Replicative adenoviruses for cancer therapy Nat Biotechnol 18 2000 723 727
3. R. Alemany S. Lai Y.C. Lou H.Y. Jan X. Fang W.W. Zhang Complementary adenoviral vectors for oncolysis Cancer Gene Ther 6 1999 21 25
4. N.S. Banerjee A.A. Rivera M. Wang L.T. Chow T.R. Broker D.T. Curiel Analyses of melanoma-targeted oncolytic adenoviruses with tyrosinase enhancer/promoter-driven E1A, E4, or both in submerged cells and organotypic cultures Mol Cancer Ther 3 2004 437 449
5. A. Bateman F. Bullough S. Murphy L. Emiliusen D. Lavillette F.L. Cosset Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth Cancer Res 60 2000 1492 1497
6. J.M. Bergelson J.A. Cunningham G. Droguett E.A. Kurt-Jones A. Krithivas J.S. Hong Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5 Science 275 1997 1320 1323
7. J. Chou Quantitation of synergism and antagonsim of two or more drugs by computerized analysis T.C. Chou D.C. Rideout Synergism and antagonism in chemotherapy 1991 Academic Press New York 223 244
8. T.C. Chou The median-effect principle and the combination index for quantitation of synergism and antagonism T.C. Chou D.C. Rideout Synergism and antagonism in chemotherapy 1991 Academic Press New York 61 102
9. T.C. Chou P. Talalay Quantitative analysis of dose–effect relationships: the combined effects of multiple drugs or enzyme inhibitors Adv Enzyme Regul 22 1984 27 55
10. C.J. Cohen J.T. Shieh R.J. Pickles T. Okegawa J.T. Hsieh J.M. Bergelson The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction Proc Natl Acad Sci USA 98 2001 15191 15196
11. T.P. Cripe E.J. Dunphy A.D. Holub A. Saini N.H. Vasi Y.Y. Mahller Fiber knob modifications overcome low, heterogeneous expression of the coxsackievirus-adenovirus receptor that limits adenovirus gene transfer and oncolysis for human rhabdomyosarcoma cells Cancer Res 61 2001 2953 2960
12. L.D. Dion K.T. Goldsmith T.V. Strong G. Bilbao D.T. Curiel R.I.J. Garver E1A RNA transcripts amplify adenovirus-mediated tumor reduction Gene Ther 3 1996 1021 1025
13. I. Dmitriev V. Krasnykh C.R. Miller M. Wang E. Kashentseva G. Mikheeva An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism J Virol 72 1998 9706 9713
14. J.T. Douglas M. Kim L.A. Sumerel D.E. Carey D.T. Curiel Efficient oncolysis by a replicating adenovirus (ad) in vivo is critically dependent on tumor expression of primary ad receptors Cancer Res 61 2001 813 817
15. M. Duchrow C. Schluter C. Wohlenberg H.D. Flad J. Gerdes Molecular characterization of the gene locus of the human cell proliferation-associated nuclear protein defined by monoclonal antibody Ki-67 Cell Prolif 29 1996 1 12
16. X. Fu L. Tao A. Jin R. Vile M.K. Brenner X. Zhang Expression of a fusogenic membrane glycoprotein by an oncolytic herpes simplex virus potentiates the viral antitumor effect Mol Ther 7 2003 748 754
17. C. Fuerer R. Iggo Adenoviruses with Tcf binding sites in multiple early promoters show enhanced selectivity for tumour cells with constitutive activation of the wnt signalling pathway Gene Ther 9 2002 270 281
18. J. Fueyo C. Gomez-Manzano R. Alemany P.S. Lee T.J. McDonnell P. Mitlianga A mutant oncolytic adenovirus targeting the Rb pathway produces anti- glioma effect in vivo Oncogene 19 2000 2 12
19. A. Gaggar D.M. Shayakhmetov A. Lieber CD46 is a cellular receptor for group B adenoviruses Nat Med 9 2003 1408 1412
20. E. Galanis A. Bateman K. Johnson R.M. Diaz C.D. James R. Vile Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas Hum Gene Ther 12 2001 811 821
21. D.J. Giard S.A. Aaronson G.J. Todaro P. Arnstein J.H. Kersey H. Dosik In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors J Natl Cancer Inst 51 1973 1417 1423
22. J. Gomez-Navarro D.T. Curiel J.T. Douglas Gene therapy for cancer Eur J Cancer 35 1999 2039 2057
23. A.M. Gown A.M. Vogel D. Hoak F. Gough M.A. McNutt Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes Am J Pathol 123 1986 195 203
24. M.J. Havenga A.A. Lemckert O.J. Ophorst M.M. van W.T. Germeraad J. Grimbergen Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease J Virol 76 2002 4612 4620
25. T.C. He S. Zhou L.T. da Costa J. Yu K.W. Kinzler B. Vogelstein A simplified system for generating recombinant adenoviruses Proc Natl Acad Sci USA 95 1998 2509 2514
26. S. Hemmi R. Geertsen A. Mezzacasa I. Peter R. Dummer The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures Hum Gene Ther 9 1998 2363 2373
27. R. Hernandez-Alcoceba M. Pihalja D. Qian M.F. Clarke New oncolytic adenoviruses with hypoxia- and estrogen receptor-regulated replication Hum Gene Ther 13 2002 1737 1750
28. D. Hoffmann J.M. Bangen W. Bayer O. Wildner Synergy between expression of fusogenic membrane proteins, chemotherapy and facultative virotherapy in colorectal cancer Gene Ther 13 2006 1534 1544
29. D. Hoffmann W. Bayer O. Wildner In situ tumor vaccination with adenovirus vectors encoding measles virus fusogenic membrane proteins and cytokines World J Gastroenterol 13 2007 3063 3070
30. D. Hoffmann W. Bayer O. Wildner Local and distant immune-mediated control of colon cancer growth with fusogenic membrane glycoproteins in combination with viral oncolysis Hum Gene Ther 18 2007 435 450
31. D. Hoffmann T. Grunwald S. Kuate O. Wildner Mechanistic analysis and comparison of viral fusogenic membrane proteins for their synergistic effects on chemotherapy Cancer Biol Ther 6 2007 510 518
32. D. Hoffmann A. Heim D.M. Nettelbeck L. Steinstraesser O. Wildner Evaluation of twenty human adenoviral types and one infectivity-enhanced adenovirus for the therapy of soft tissue sarcoma Hum Gene Ther 18 2007 51 62
33. D. Hoffmann B. Meyer O. Wildner Improved glioblastoma treatment with Ad5/35 fiber chimeric conditionally replicating adenoviruses J Gene Med 9 2007 764 778
34. D. Hoffmann O. Wildner Restriction of adenoviral replication to the transcriptional intersection of two different promoters for colorectal and pancreatic cancer treatment Mol Cancer Ther 5 2006 1 8
35. D. Hoffmann O. Wildner Efficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coli BMC Biotechnol 6 2006 36
36. D. Hoffmann O. Wildner Enhanced killing of pancreatic cancer cells by expression of fusogenic membrane glycoproteins in combination with chemotherapy Mol Cancer Ther 5 2006 2013 2022
37. I. Horikawa P.L. Cable C. Afshari J.C. Barrett Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene Cancer Res 59 1999 826 830
38. H. Inoue T. Tanabe K. Umesono Feedback control of cyclooxygenase-2 expression through PPARgamma J Biol Chem 275 2000 28028 28032
39. S. Inoue M. Shanker R. Miyahara B. Gopalan S. Patel Y. Oida MDA-7/IL-24-based cancer gene therapy: translation from the laboratory to the clinic Curr Gene Ther 6 2006 73 91
40. A. Jemal R. Siegel E. Ward T. Murray J. Xu M.J. Thun Cancer statistics, 2007 CA Cancer J Clin 57 2007 43 66
41. L. Johnson A. Shen L. Boyle J. Kunich K. Pandey M. Lemmon Selectively replicating adenoviruses targeting deregulated E2F activity are potent, systemic antitumor agents Cancer Cell 1 2002 325 337
42. T.M. Johnson J.W. Smith B.R. Nelson A. Chang Current therapy for cutaneous melanoma J Am Acad Dermatol 32 1995 689 707
43. F.R. Khuri J. Nemunaitis I. Ganly J. Arseneau I.F. Tannock L. Romel A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer Nat Med 6 2000 879 885
44. C.T. Lee K.H. Park K. Yanagisawa Y. Adachi J.E. Ohm S. Nadaf Combination therapy with conditionally replicating adenovirus and replication defective adenovirus Cancer Res 64 2004 6660 6665
45. A.A. Lemckert J. Grimbergen S. Smits E. Hartkoorn L. Holterman B. Berkhout Generation of a novel replication-incompetent adenoviral vector derived from human adenovirus type 49: manufacture on PER.C6 cells, tropism and immunogenicity J Gen Virol 87 2006 2891 2899
46. H. Li Y.S. Haviv C.A. Derdeyn J. Lam C. Coolidge E. Hunter Human immunodeficiency virus type 1-mediated syncytium formation is compatible with adenovirus replication and facilitates efficient dispersion of viral gene products and de novo -synthesized virus particles Hum Gene Ther 12 2001 2155 2165
47. X. Li Y.P. Zhang H.S. Kim K.H. Bae K.M. Stantz S.J. Lee Gene therapy for prostate cancer by controlling adenovirus E1a and E4 gene expression with PSES enhancer Cancer Res 65 2005 1941 1951
48. Y. Li R.C. Pong J.M. Bergelson M.C. Hall A.I. Sagalowsky C.P. Tseng Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy Cancer Res 59 1999 325 330
49. M. Liu B. Acres J.M. Balloul N. Bizouarne S. Paul P. Slos Gene-based vaccines and immunotherapeutics Proc Natl Acad Sci USA 101 Suppl 2 2004 14567 14571
50. S.A. Lukashok M.S. Horwitz New perspectives in adenoviruses Curr Clin Top Infect Dis 18 1998 286 305
51. J.V. Maizel Jr D.O. White M.D. Scharff The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12 Virology 36 1968 115 125
52. M. Marttila D. Persson D. Gustafsson M.K. Liszewski J.P. Atkinson G. Wadell CD46 is a cellular receptor for all species B adenoviruses except types 3 and 7 J Virol 79 2005 14429 14436
53. O. Meier U.F. Greber Adenovirus endocytosis J Gene Med 6 Suppl 1 2004 S152 S163
54. N. Mittereder K.L. March B.C. Trapnell Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy J Virol 70 1996 7498 7509
55. T. Nakamura K.W. Peng S. Vongpunsawad M. Harvey H. Mizuguchi T. Hayakawa Antibody-targeted cell fusion Nat Biotechnol 22 2004 331 336
56. T. Nakamura K. Sato H. Hamada Effective gene transfer to human melanomas via integrin-targeted adenoviral vectors Hum Gene Ther 13 2002 613 626
57. D.M. Nettelbeck A.A. Rivera J. Davydova D. Dieckmann M. Yamamoto D.T. Curiel Cyclooxygenase-2 promoter for tumour-specific targeting of adenoviral vectors to melanoma Melanoma Res 13 2003 287 292
58. D.M. Nettelbeck A.A. Rivera J. Kupsch D. Dieckmann J.T. Douglas R.E. Kontermann Retargeting of adenoviral infection to melanoma: combining genetic ablation of native tropism with a recombinant bispecific single-chain diabody (scDb) adapter that binds to fiber knob and HMWMAA Int J Cancer 108 2004 136 145
59. M. Nilsson J. Ljungberg J. Richter T. Kiefer M. Magnusson A. Lieber Development of an adenoviral vector system with adenovirus serotype 35 tropism; efficient transient gene transfer into primary malignant hematopoietic cells J Gene Med 6 2004 631 641
60. Y. Okada N. Okada H. Mizuguchi T. Hayakawa S. Nakagawa T. Mayumi Transcriptional targeting of RGD fiber-mutant adenovirus vectors can improve the safety of suicide gene therapy for murine melanoma Cancer Gene Ther 12 2005 608 616
61. Z. Ram K.W. Culver E.M. Oshiro J.J. Viola H.L. DeVroom E. Otto Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells Nat Med 3 1997 1354 1361
62. C.D. Richardson A. Scheid P.W. Choppin Specific inhibition of paramyxovirus and myxovirus replication by oligopeptides with amino acid sequences similar to those at the N-termini of the F1 or HA2 viral polypeptides Virology 105 1980 205 222
63. M. Schmitz C. Graf T. Gut D. Sirena I. Peter R. Dummer Melanoma cultures show different susceptibility towards E1A-, E1B-19 kDa- and fiber-modified replication-competent adenoviruses Gene Ther 13 2006 893 905
64. A. Segerman N. Arnberg A. Erikson K. Lindman G. Wadell There are two different species B adenovirus receptors: sBAR, common to species B1 and B2 adenoviruses, and sB2AR, exclusively used by species B2 adenoviruses J Virol 77 2003 1157 1162
65. A. Segerman J.P. Atkinson M. Marttila V. Dennerquist G. Wadell N. Arnberg Adenovirus type 11 uses CD46 as a cellular receptor J Virol 77 2003 9183 9191
66. D.M. Shayakhmetov T. Papayannopoulou G. Stamatoyannopoulos A. Lieber Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector J Virol 74 2000 2567 2583
67. D. Sirena B. Lilienfeld M. Eisenhut S. Kalin K. Boucke R.R. Beerli The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3 J Virol 78 2004 4454 4462
68. C.D. Smith D.W. Craft R.S. Shiromoto P.O. Yan Alternative cell line for virus isolation J Clin Microbiol 24 1986 265 268
69. T.A. Smith N. Idamakanti M.L. Rollence J. Marshall-Neff J. Kim K. Mulgrew Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice Hum Gene Ther 14 2003 777 787
70. K. Subbaramaiah D. Zakim B.B. Weksler A.J. Dannenberg Inhibition of cyclooxygenase: a novel approach to cancer prevention Proc Soc Exp Biol Med 216 1997 201 210
71. R.P. Tomko R. Xu L. Philipson HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses Proc Natl Acad Sci USA 94 1997 3352 3356
72. S. Tuve H. Wang C. Ware Y. Liu A. Gaggar K. Bernt A new group B adenovirus receptor is expressed at high levels on human stem and tumor cells J Virol 80 2006 12109 12120
73. A.L. Volk A.A. Rivera A. Kanerva G. Bauerschmitz I. Dmitriev D.M. Nettelbeck Enhanced adenovirus infection of melanoma cells by fiber-modification: incorporation of RGD peptide or Ad5/3 chimerism Cancer Biol Ther 2 2003 511 515
74. J.D. Wagner M.S. Gordon T.Y. Chuang J.J. Coleman III Current therapy of cutaneous melanoma Plast Reconstr Surg 105 2000 1774 1799
75. T.J. Wickham E.J. Filardo D.A. Cheresh G.R. Nemerow Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization J Cell Biol 127 1994 257 264
76. T.J. Wickham P. Mathias D.A. Cheresh G.R. Nemerow Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment Cell 73 1993 309 319
77. O. Wildner Comparison of replication-selective, oncolytic viruses for the treatment of human cancers Curr Opin Mol Ther 5 2003 351 361
78. O. Wildner R.M. Blaese J.C. Morris Therapy of colon cancer with oncolytic adenovirus is enhanced by the addition of herpes simplex virus-thymidine kinase Cancer Res 59 1999 410 413
79. O. Wildner J.C. Morris N.N. Vahanian H. Ford Jr W.J. Ramsey R.M. Blaese Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer Gene Ther 6 1999 57 62
80. J.M. Wilson Adenoviruses as gene-delivery vehicles N Engl J Med 334 1996 1185 1187
81. A.M. Witlox V. Van B B. Molenaar H. Bras G.R. Schaap R. Alemany Conditionally replicative adenovirus with tropism expanded towards integrins inhibits osteosarcoma tumor growth in vitro and in vivo Clin Cancer Res 10 2004 61 67
82. M.A. Witlox V. Van B J. Grill H.J. Haisma G. Schaap J. Bras Epidermal growth factor receptor targeting enhances adenoviral vector based suicide gene therapy of osteosarcoma J Gene Med 4 2002 510 516
83. G.W. Wolkersdorfer J.C. Morris G. Ehninger W.J. Ramsey Trans-complementing adenoviral vectors for oncolytic therapy of malignant melanoma J Gene Med 6 2004 652 662
84. E. Wu S.A. Trauger L. Pache T.M. Mullen D.J. Von Seggern G. Siuzdak Membrane cofactor protein is a receptor for adenoviruses associated with epidemic keratoconjunctivitis J Virol 78 2004 3897 3905
85. X.B. Xiong Y. Huang W.L. Lu X. Zhang H. Zhang T. Nagai Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy: in vitro and in vivo J Pharm Sci 94 2005 1782 1793
86. Y. Zhang J.M. Bergelson Adenovirus receptors J Virol 79 2005 12125 12131